Results from a Model to Forecast The Current and Future Number of Patients Eligible for Treatment of Refractory Advanced Non-Small Cell Lung Cancer (NSCLC) in France, Germany, Italy and Spain
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.2364
https://www.valueinhealthjournal.com/article/S1098-3015(16)33730-5/fulltext
Section Title :
Disease-Specific Studies
Section Order :
2241
First Page :
A760
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33730-5&doi=10.1016/j.jval.2016.09.2364